GLP1R and diabetes mellitus: GLP-1 receptor agonists (GLP-1RAs) are now a cornerstone treatment of type 2 diabetes mellitus (DM) in human medicine (2), with exenatide being the first-in-class GLP-1RA to be approved (3).